2020
DOI: 10.1038/s41598-020-76893-7
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of a 4-color multiplexing spinal muscular atrophy (SMA) genotyping assay on a novel integrated digital PCR instrument

Abstract: Digital PCR (dPCR) technology has been proven to be highly sensitive and accurate in detecting copy number variations (CNV). However, a higher-order multiplexing dPCR assay for measuring SMN1 and SMN2 copy numbers in spinal muscular atrophy (SMA) samples has not been reported. Described here is a rapid multiplex SMA dPCR genotyping assay run on a fully integrated dPCR instrument with five optical channels. The hydrolysis probe-based multiplex dPCR assay quantifies SMN1, SMN2, and the total SMN (SMN1 + SMN2) wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 46 publications
(68 reference statements)
0
18
0
Order By: Relevance
“…The droplet digital PCR is another emerging technique for SMN1 copy number assay 47 51 . Although, the improved digital PCR technology has been reported 52 , the most are operational complexity and the related equipment and reagents are expensive. At present, it is mostly used as a validation method for positive results 22 , 53 and has not been adopted extensively for carrier screening of SMA.…”
Section: Discussionmentioning
confidence: 99%
“…The droplet digital PCR is another emerging technique for SMN1 copy number assay 47 51 . Although, the improved digital PCR technology has been reported 52 , the most are operational complexity and the related equipment and reagents are expensive. At present, it is mostly used as a validation method for positive results 22 , 53 and has not been adopted extensively for carrier screening of SMA.…”
Section: Discussionmentioning
confidence: 99%
“…Genome sequencing data from the 37 SMA patients and the two healthy individuals have been previously published by the Motor Neuron Diseases Research Laboratory (MNDRL, Wilmington, DE, USA) in collaboration with Illumina, Inc. (San Diego, CA, USA) [ 41 ]. The SMA status as well as SMN1 and SMN2 copy numbers for the MNDRL cohort were confirmed by digital droplet PCR ( Table 2 ) [ 42 , 43 , 44 ]. We also analyzed the reference SMN1 sequence (gene ID: ENSG00000172062, human genome assembly GRCh38, p13) that is available in Ensemble.…”
Section: Methodsmentioning
confidence: 98%
“…The master mix was loaded onto the Absolute Q microfluidic array partitioning plate, and the isolation buffer (Thermo Fisher Scientific) was overlaid. The dPCR plate was run in the Applied Biosystems QuantStudio Absolute Q dPCR System with a program of 96°C for 10 min, followed by 45 cycles at 96°C for 5 s and 60°C for 30 s. This dPCR system has been described in detail previously ( 107 ). Primer and probe information for dPCR are listed in table S1.…”
Section: Methodsmentioning
confidence: 99%